Open main menu
Search Ctrl + K
Sign up for free
Loading...
Y-mabs Therapeutics, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.YMAB
230 Park Avenue, Suite 3350, New York, NY, 10169
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
News
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
12 Aug 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Financial Statements And Exhibits
19 Jul 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
01 Jul 24
8-K
Other Events
28 Jun 24
8-K
Submission Of Matters To A Vote Of Security Holders
13 Jun 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
07 May 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers
29 Apr 24
Other
ARS
Scanned Paper Annual Report Submission.
29 Apr 24
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
05 May 23
CORRESP
Correspondence With The Sec.
02 May 23
ARS
Scanned Paper Annual Report Submission.
28 Apr 23
UPLOAD
Letter From The Sec.
03 Apr 23
S-3
Registration Statement Under The Securities Act.
30 Mar 23
SEC STAFF LETTER
Correspondence Between The Sec's Staff And Filers.
28 Feb 20
Proxies
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
29 Apr 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
29 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
29 Apr 22
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
29 Apr 22
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 21
Prospectuses and Registrations
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
29 Feb 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
30 Mar 23
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
18 Feb 21
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
17 Feb 21
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
31 Oct 19
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
29 Oct 19
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
22 Mar 19
Financials
10-Q
Quarterly Filing
12 Aug 24
10-Q
Quarterly Filing
07 May 24
10-K
Fiscal Year 2024
29 Feb 24
10-Q
Quarterly Filing
13 Nov 23
10-Q
Quarterly Filing
10 Aug 23
10-Q
Quarterly Filing
08 May 23
10-K
Fiscal Year 2022
30 Mar 23
Ownership
144
Ber Gerard
03 Sep 24
4
Lund-hansen Torben
30 Aug 24
144
Lund-hansen Torben
28 Aug 24
4
Wilms Joris
27 Aug 24
144
Wilms Joris
26 Aug 24
4
Pfreundschuh Peter P.
12 Jul 24
3
Pfreundschuh Peter P.
08 Jul 24